UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The American journal of cardiology, ISSN 0002-9149, 2017, Volume 119, Issue 11, pp. 1703 - 1709
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prognosis | Survival Rate - trends | Angina Pectoris - diagnosis | Humans | Middle Aged | Risk Factors | Male | Incidence | Angina Pectoris - complications | Coronary Angiography - methods | Diabetes Mellitus - epidemiology | Hospitalization - trends | Angina Pectoris - epidemiology | Cause of Death - trends | Female | Registries | Aged | Retrospective Studies | North Carolina - epidemiology | Diabetics | Medical research | Patient outcomes | Mortality | Medicine, Experimental | Diagnostic imaging | Diabetes | Cardiovascular diseases | Angina pectoris | Cardiology | Myocardial infarction | Heart attacks | Angiography | Laboratories | Cardiomyopathy | Risk | Cardiovascular disease | Diabetic neuropathy | Family medical history | Angina | Neuropathy | Confidence intervals | Ischemia | Heart diseases | Heart failure | Medical imaging | Diabetes mellitus | Health risks | Coronary artery | Regression analysis | Coronary artery disease | Disease control | Patients | Studies | Coronary vessels | Infarction | Intubation | Health risk assessment | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2019, Volume 380, Issue 6, pp. 539 - 548
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Heart failure | Hospital patients | Care and treatment | Valsartan | Angiotensin | Dosage and administration | Research | Health aspects | Brain natriuretic peptide | Heart attacks | Renal function | Inhibitor drugs | Peptides | Angioedema | Hospitalization | Hypotension | Hyperkalemia | Patient safety | Neprilysin | Blood pressure | Heart diseases | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
3.
Full Text
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2017, Volume 70, Issue 20, pp. 2476 - 2486
heart failure | ejection fraction | outcomes | survival | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Age Factors | United States | Humans | Heart Failure - physiopathology | Stroke Volume - physiology | Male | Survival Rate | Hospitalization | Heart Failure - therapy | Time Factors | Aged, 80 and over | Female | Aged | Retrospective Studies | Heart Failure - mortality | Heart failure | Cardiac patients | Analysis | Health care | Heart | Stroke | Medicare | Review boards | Mortality | Health risks | Risk analysis | Patients | Survival | Subgroups | Confidence intervals | Demographics | Government programs | Medical prognosis | Rehabilitation | Cardiology | Cardiovascular diseases | Heart diseases | Age | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2019, Volume 74, Issue 2, pp. 235 - 237
heart failure | hospital readmission rates | outcomes | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Happiness | Hospitals | Medicare | Patient Readmission | United States | Humans | Patient-Centered Care | Mortality | Cardiovascular disease | Patient admissions | Patients | Quality of care | Patient Protection & Affordable Care Act 2010-US
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2019, Volume 73, Issue 24, pp. 3064 - 3066
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Blood Pressure | Stroke Volume | Heart Failure | Ventricular Dysfunction, Left | Humans | Heart failure | Hypertension | Enzymes | Therapy | Mortality | Clinical trials | Beta blockers | Patients | Clinical outcomes | Hypotension | Side effects | Physiology | Blood pressure | Titration | Heart diseases | Drug dosages
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2019, Volume 73, Issue 14, pp. 1779 - 1780
ventricular assist devices | mechanical support | advanced heart failure | renin-angiotensin system | gastrointestinal bleeding | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Renin-Angiotensin System | Angiotensin II | Gastrointestinal Hemorrhage | Heart-Assist Devices | Humans | Heart failure | Stroke | Transplants & implants | Gastrointestinal system | Blood pressure | Drug therapy | ACE inhibitors | Bleeding
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2018, Volume 72, Issue 4, pp. 351 - 366
reduced ejection fraction | registry | dose | medication | Severity of Illness Index | Mineralocorticoid Receptor Antagonists - administration & dosage | United States - epidemiology | Age Factors | Humans | Middle Aged | Heart Failure - physiopathology | Male | Socioeconomic Factors | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Dose-Response Relationship, Drug | Stroke Volume | Quality Improvement | Registries - statistics & numerical data | Female | Aged | Angiotensin Receptor Antagonists - therapeutic use | Heart Failure - epidemiology | Adrenergic beta-Antagonists - administration & dosage | Drug Utilization - statistics & numerical data | Adrenergic beta-Antagonists - therapeutic use | Angiotensin Receptor Antagonists - administration & dosage | Practice Guidelines as Topic | Health care | Angiotensin-converting enzyme inhibitors | Drugs | Therapy | Cardiac arrhythmia | Health services | Medical records | Clinical trials | Cardiovascular disease | Secondary schools | Regulatory approval | Renal insufficiency | Enzyme inhibitors | Peptidyl-dipeptidase A | Blood pressure | Cardiology | Angiotensin II | Heart diseases | Age | Heart failure | Hypertension | Mortality | Hospitalization | Patients | Asthma | Heart rate | Ethnicity | Inhibitors | Coronary vessels | Angiotensin | Neprilysin | Diabetes | Clinical medicine | Females | Hispanics | Ejection fraction
Journal Article
The American heart journal, ISSN 0002-8703, 2016, Volume 182, pp. 9 - 20
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | United States - epidemiology | Prevalence | Hospital Mortality | Comorbidity | Humans | Middle Aged | Heart Failure - physiopathology | Hospitalization - statistics & numerical data | Male | Socioeconomic Factors | Stroke Volume | Diabetes Mellitus - epidemiology | Hospitalization - trends | Aged, 80 and over | Female | Registries | Aged | Heart Failure - diagnosis | Diabetes Mellitus - diagnosis | Heart Failure - epidemiology | Heart failure | Medicine, Experimental | Medical research | Diabetes | Cardiac patients | Anticoagulants | Immunization | Mortality | African Americans | Cardiovascular disease | Family medical history | Patients | Influenza | Quality | Blood pressure | Trends | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2019, Volume 73, Issue 19, pp. 2365 - 2383
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prospective Studies | Humans | Middle Aged | Heart Failure - physiopathology | Male | Heart Failure - drug therapy | Dose-Response Relationship, Drug | Stroke Volume | Ventricular Dysfunction, Left - drug therapy | Quality of Life | Female | Aged | Drug Therapy, Combination | Angiotensin-converting enzyme inhibitors | Heart | Drugs | Therapy | Identification methods | Clinical trials | Cardiovascular disease | Secondary schools | Multivariate analysis | Beta blockers | Confidence intervals | Enzyme inhibitors | Peptidyl-dipeptidase A | Education | Blood pressure | Angiotensin II | Heart diseases | Heart failure | Medical research | Family income | Enrollments | Hospitalization | Patients | Quality of life | Ethnicity | Inhibitors | Quality control | Angiotensin | Titration | Neprilysin | Clinical medicine | Ejection fraction
Journal Article
The American journal of cardiology, ISSN 0002-9149, 02/2016, Volume 117, Issue 3, pp. 404 - 411
Cardiovascular | UNITED-STATES | MANAGEMENT | THERAPY | MYOCARDIAL FIBROSIS | TORASEMIDE | QUALITY-OF-LIFE | OUTCOMES | DIURETIC TREATMENT | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Furosemide - administration & dosage | Acute Disease | Survival Rate - trends | Double-Blind Method | Follow-Up Studies | Global Health | Humans | Middle Aged | Heart Failure - physiopathology | Stroke Volume - drug effects | Male | Treatment Outcome | Heart Failure - drug therapy | Dose-Response Relationship, Drug | Hospitalization - trends | Cause of Death - trends | Female | Aged | Retrospective Studies | Sodium Potassium Chloride Symporter Inhibitors - administration & dosage | Sulfonamides - administration & dosage | Heart Failure - mortality | Heart failure | Care and treatment | Analysis | Mortality | Cardiac patients | Furosemide | Natriuretic peptides | Confidence intervals | Variables | Heart attacks | Laboratories | Diuretics | Nitrogen | Patients | Logistics | Index Medicus | Abridged Index Medicus | furosemide | heart failure | torsemide | loop diuretics
Journal Article
The American heart journal, ISSN 0002-8703, 2017, Volume 186, pp. 130 - 138
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart Failure - rehabilitation | Humans | Middle Aged | Heart Failure - physiopathology | Stroke Volume - physiology | Depression | Male | Treatment Outcome | Exercise Therapy | Activities of Daily Living | Quality of Life | Female | Surveys and Questionnaires | Aged | Health Status | Heart Failure - psychology | Heart failure | Training | Medical personnel | Patient outcomes | Cardiac patients | Exercise therapy | Medical research | Analysis | Medicine, Experimental | Heart | Heart attacks | Discomfort | Clinical trials | Family medical history | Mental depression | Beta blockers | Visual perception | Exercise | Pain | Ischemia | Anxiety | Heart diseases | Fitness training programs | Mortality | Health risks | Aerobics | Patients | Coronary artery disease | Morbidity | Quality of life | Studies | Physical fitness | Medical prognosis | Quality assessment | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2019, Volume 73, Issue 5, pp. 602 - 611
heart failure | clinical trials | comorbidity | registries | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Stroke Volume | Comorbidity | Diabetes Mellitus - physiopathology | Diabetes Mellitus - epidemiology | Humans | Heart Failure - physiopathology | Disease Management | Heart Failure - metabolism | Heart Failure - epidemiology | Heart failure | Hypertension | Medical research | Phenotypes | Therapeutic applications | Mortality | Diabetes mellitus | Clinical trials | Muscles | Morbidity | Skeletal muscle | Genotype & phenotype | Sodium | Adults | Diabetes | Clinical medicine | Kidney diseases | Heart diseases | Ejection fraction
Journal Article
The American heart journal, ISSN 0002-8703, 2015, Volume 173, pp. 172 - 178
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Heart Failure - physiopathology | Patient Discharge | Male | Treatment Outcome | Heart Failure - drug therapy | Dose-Response Relationship, Drug | Heart Rate - drug effects | Heart Rate - physiology | Female | Registries | Aged | Retrospective Studies | Adrenergic beta-Antagonists - administration & dosage | Heart failure | Cardiac arrhythmia | Enzymes | Mortality | Hospitalization | Family medical history | FDA approval | Dosage | Patients | Beta blockers | Discharge | Heart rate | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article